New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis
- PMID: 15585303
- DOI: 10.1016/j.imlet.2004.07.017
New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis
Abstract
Animal models of autoimmune diseases such as experimental autoimmune encephalomyelitis (EAE) are inflammatory demyelinating diseases which comprise a heterogeneous group of disorders that affect the peripheral and central nervous systems. EAE presents close similarities with multiple sclerosis (MS), a chronic inflammatory disease affecting central nervous system (CNS) white matter. Many studies have shown EAE to be a particularly useful animal model for the understanding of both the mechanisms of immune-mediated CNS pathology and the progressive clinical course of multiple sclerosis. Previous data has underlined the importance of CD4+ T cell involvement in mediating the autoimmune processes associated with the destruction of myelin and the role of the T helper 1 (Th1) pattern of cytokine secretion. However, EAE studies have also demonstrated that other cells involved in innate and/or adaptive immune responses may also play a critical role in the early and progressive events of the immune reaction leading to inflammation and CNS damage. In this review, we present such new data and discuss their potent implication for future new therapeutical approaches.
Similar articles
-
Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.Ann Anat. 2010 Aug 20;192(4):179-93. doi: 10.1016/j.aanat.2010.06.006. Epub 2010 Jul 15. Ann Anat. 2010. PMID: 20692821 Review.
-
[Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis].Rev Neurol. 2003 Apr 1-15;36(7):649-52. Rev Neurol. 2003. PMID: 12666047 Review. Spanish.
-
Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis.J Immunol. 1998 Oct 15;161(8):4437-46. J Immunol. 1998. PMID: 9780223
-
MASTering the immune response: mast cells in autoimmunity.Novartis Found Symp. 2005;271:215-25; discussion 225-31. Novartis Found Symp. 2005. PMID: 16605138 Review.
-
CD8+ T cells in inflammatory demyelinating disease.J Neuroimmunol. 2007 Nov;191(1-2):79-85. doi: 10.1016/j.jneuroim.2007.09.011. Epub 2007 Oct 24. J Neuroimmunol. 2007. PMID: 17920696 Review.
Cited by
-
Comparison of serum apolipoprotein A-I between Chinese multiple sclerosis and other related autoimmune disease.Lipids Health Dis. 2010 Mar 29;9:34. doi: 10.1186/1476-511X-9-34. Lipids Health Dis. 2010. PMID: 20350318 Free PMC article.
-
Extracellular Vesicles as Pro- and Anti-inflammatory Mediators, Biomarkers and Potential Therapeutic Agents in Multiple Sclerosis.Aging Dis. 2021 Sep 1;12(6):1451-1461. doi: 10.14336/AD.2021.0513. eCollection 2021 Sep. Aging Dis. 2021. PMID: 34527421 Free PMC article. Review.
-
H(1)R expression by CD11B(+) cells is not required for susceptibility to experimental allergic encephalomyelitis.Cell Immunol. 2012 Jul-Aug;278(1-2):27-34. doi: 10.1016/j.cellimm.2012.06.012. Epub 2012 Jul 14. Cell Immunol. 2012. PMID: 23121973 Free PMC article.
-
Combinatorial roles for histamine H1-H2 and H3-H4 receptors in autoimmune inflammatory disease of the central nervous system.Eur J Immunol. 2012 Jun;42(6):1536-46. doi: 10.1002/eji.201141859. Eur J Immunol. 2012. PMID: 22678907 Free PMC article.
-
Neuroprotective Potential of Dendritic Cells and Sirtuins in Multiple Sclerosis.Int J Mol Sci. 2022 Apr 14;23(8):4352. doi: 10.3390/ijms23084352. Int J Mol Sci. 2022. PMID: 35457169 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials